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Background. To review evidence supporting the use of endovascular ruptured aneurysm repair (EVRAR) for treatment of
ruptured abdominal aortic aneurysm (RAAA).
Methods. A systematic review of the medical literature was performed for relevant studies. We searched a number of elec-
tronic databases and hand-searched relevant journals until November 2006 to identify studies for inclusion. We considered
studies in which patients with a confirmed ruptured abdominal aortic aneurysm were treated with EVRAR, which reported
endpoints of mortality and major complications.
Results. There was 1 randomised controlled trial (RCT), 33 non-randomised case series (24 retrospective and 9 prospec-
tive) reports were identified comparing EVRAR (n¼ 891) with conventional open surgical repair for the treatment of
RAAA. Whilst no benefit in the primary outcome of mortality was noted in the only RCT, evidence from non-randomised
studies suggest that EVRAR is feasible in selected patients, where it may be associated with a trend towards reductions in
blood loss, duration of intensive care treatment, early complications, and mortality.
Conclusions. For the treatment of symptomatic or ruptured abdominal aortic aneurysm, emergency endovascular repair
(EVRAR) is feasible in selected patients, with early outcomes comparable to best conventional open surgical repair for the
treatment of RAAA.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysm (AAA), affects between
1.2% and 7.6% of the population over 50 years of age
in theUnitedKingdom.1,2 Untreated, progressive aneu-
rysm enlargement can lead to rupture,which is lethal in
80% of those affected and responsible for over 6800
deaths per annum in the United Kingdom and 2.1% of
all deaths in men over 65 years.2,3 Excellent results can
now be achieved with elective open repair, with some
specialist centres reporting mortality rates of less than
2% and surgeons in non-specialist units achieving
mortality rates of 5% to 8%.4e7 This contrasts with
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in these critically ill patients, which carries a mortality
rate of 30% to 65%.4,8,9 In the last two decades a new
minimally-invasive technique, endovascular aneurysm
repair (EVAR), hasofferedanalternative therapy to con-
ventional open repair for selected patients with AAA,
and has shown significant reductions in early complica-
tions and mortality.10,11 Furthermore, several studies
have shown that EVAR, especially under local anaesthe-
sia, reduces the physiological insult to the body as com-
pared to conventional open surgical repair.12,13 This has
led some to consider emergency endovascular aneu-
rysm repair (EVRAR) as an alternative to conventional
open repair in selected patients with RAAA.13e15
This article reviews the available published evi-
dence to support the use of emergency endovascular
aneurysm repair (EVRAR) as compared to conven-
tional open repair (OR) of RAAA, for patients with
RAAA.lar Surgery. Published by Elsevier Ltd. All rights reserved.
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Criteria for considering studies
Our objective was to review the published evidence to
allow assessment of the advantages and disadvantages
of EVAR for patients with RAAA (EVRAR). This was
determined by the effect on short-termmortality, major
complication rates, aneurysm exclusion, and late com-
plications when comparedwith patients who have had
conventional open repair of RAAA. To ensure compa-
rability of participants were considered for inclusion.
There must have been evidence of rupture on imaging,
computerised tomography angiography (CTA) or
magnetic resonance angiography (MRA), or objective
acute symptoms suggestive of impending rupture of
a knownaneurysm (abdominal or backpain in apatient
with an aneurysm) to warrant inclusion. Studies
where objective evidence of RAAA is not clear were
excluded.
We did not limit our search in respect to the type of
endovascular intervention or device type.
The following outcome measures were considered:
(1) mortality (30 day, or in-hospital mortality, i.e. pro-
cedure related); (2) aneurysm exclusion (no flow in
the AAA sac, or further extravasation (escape of blood
from the vessel into the tissues) beyond the sac on
follow-up imaging 30 days after the procedure); (3)
comparative surrogate measures of procedural suc-
cess (blood loss, procedural time, ICU stay). Data
was sought for other important outcome measures,
such as: major complications (i.e. open conversion,
haemorrhage, myocardial infarction, stroke, renal
failure, respiratory failure, pneumonia, bowel ischae-
mia, lower limb ischaemia); minor complications (i.e.
haematoma, wound infection); long term complica-
tions, re-intervention rates and mortality. However,
these data were inconsistently reported and as
such comments were possible pertain to individual
studies.
Search strategy
We searched for articles using the broad terms ‘‘endo-
vascular’’ AND ‘‘abdominal aortic aneurysm’’ AND
‘‘ruptured’’ in all databases. The last search prior to
preparation of this reviewwasperformed inNovember
2006. We searched the Cochrane Peripheral Vascular
Diseases Group trials register (last searched October
2006) and the Cochrane Central Register of Controlled
Trials (CENTRAL) database (last searched Issue 4,
2006) for trials describing endovascular repair of rup-
tured or symptomatic abdominal aortic aneurysm.Eur J Vasc Endovasc Surg Vol 34, December 2007We performed electronic searches of the following bib-
liographic databases: (1) AMED (Allied and Comple-
mentary Medicine Database); (2) Best Evidence; (3)
Biological Abstracts (4) HMIC (Health Management
of Information Consortium e comprising DH-data,
the King’s Fund Database and Helmis); (5) NHS
DARE (Database ofAssessments of Reviews of Effects);
(6) NHS EED (Economics Evaluations Database);
(7) NHS HTA (Health Technology Assessment);
(8) PubMed; (9) Science Citation Index; (10)MEDLINE.
In order to collect any articles missed by searches we
also hand-searched relevant journals, retrieved articles,
and relevant. Searches were not restricted by publica-
tion type, study design or language of publication.
Selection
Authors, M.D. and D.W.H., evaluated the trials under
consideration independently for appropriateness for
inclusion and for methodological quality. Disagree-
ments were resolved on discussion with the review
team and agreed arbitrators. The searches identified
41 potentially relevant articles comparing EVRAR
with conventional open surgical repair for the treat-
ment of RAAA to which exclusion criteria were ap-
plied: 1 randomised controlled trial; 33 case series
(24 retrospective and 9 prospective); 7 case reports.
Only 1 RCT was identified, and as such no tests of
heterogeneity or sensitivity analysis were performed,
and meta-analysis was not indicated.
Results
There was only 1 completed randomised controlled
trial (RCT)16 comparing EVRAR with conventional
open surgical repair for the treatment of RAAA.
Thirty-three case series (24 retrospective and 9
prospective)13e15,17e46 describing EVRAR (in 876
patients) were identified, Table 1. A number of case-
control studies and cohort studies comparing out-
comes of EVRAR with open surgical repair (OR)
were found,13,15,17e19,22,24,27,30,31,35,38,41,44e46 these were
invariably non-randomised and in some cases the
EVRAR had been compared to historical controls.
Therefore, the following review has limited high-
quality evidence on which to base strong recommen-
dations, but endeavours to present the available
evidence as succinctly as possible.
Hinchcliffe et al.,16 in late 2006 reported the results
of a pilot study as part of an ongoing randomised con-
trolled trial comparing endovascular (EVRAR) and
open surgery (OR) for the treatment of ruptured ab-
dominal aortic aneurysm (RAAA). The trialists
675Endovascular RAAA RepairTable 1. Mortality after endovascular ruptured aneurysm repair (EVRAR)
Study Design %EVAR Suitable* EVRAR OPEN group (if quoted) p value (if quoted)
Hinchcliffe 2006 PRCT 93% 8/15 (53) 9/17 (53%) NS
Franks 2006 PCSy 100% 1/10 (10) 7/10 (70) e
Arya 2006 PCCS 42% 4/17 (24) 11/23 (47) NS
Lagana 2006 CS 4/38 (10.5)
Visser 2006 RCS 47% 8/26 (31) 9/29 (31) NS
Alsac 2005 PCS 73% 4/17 (23.5) 10/20 (50) 0.09
Brandt 2005 RCS 72% 0/11 (0) 2/13 (15) NS
Greco 2005 RCS e 114/290 (39) 2627/5508 (47) 0.05
Kapma 2005 RCS 36% 5/40 (13) 64/213 (30) 0.02
Larzon 2005 RCS e 2/15 (13) 12/26 (46) 0.05
Peppelenbosch 2005 RCS 8/35 (23) e
Vaddineni 2005 RCS 60% 2/9 (22) 4/15 (26) NS
Castelli 2005 CS 5/25 (20)
Gerassimidis 2005 CS 9/23 (39)
Hechelhammer 2005 CS 4/37 (10.4)
Mehta 2005 CS 7/30 (23)
Lombardi 2004 CS 0/5 (0)
Lee 2004 RCS 88% 1/13 (7.7) 1/4 (25) e
Rubin 2004 CS 1/5 (20)
Peppelenbosch 2003 PCSy 80% 4/26 (15) 4/14 (28) e
Reichart 2003 PCS 42% 1/6 (16.6) 4/13 (30) e
Resch 2003 PCS 79% 4/14 (29) 8/23 (35) 0.05
Scharrer-Pamler 2003 CS 3/24 (12.5)
Van Herzeele 2003 CS 1/9 (11)
Verhoeven 2002 PCS 34% 1/9 (11) 7/31 (23) e
Yilmaz 2002 PCS 81% 4/17 (24) 12/29 (41) NS
Doss 2002 CS 0/6 (0)
Lachat 2002 CS 2/21 (9.5)
Orend 2002 CS 4/21 (19)
Van Sambeek 2002 CS 6/22 (19)
Hinchcliffe 2001 CS 9/20 (45)
Ohki 2000 PCS 80% 2/20 (10) 0/5 (0) e
Greenberg 2000 CS 0/3 (0)
Ohki 1999 CS 2/12 (17)
Overall13,15,16,18e47 67% (34e100) 18% (0e53) 34% (0e70)
Data in parenthesis represents (%) or (range).13,15,16,18e47 Prospective Randomised Controlled Trial (PRCT); Prospective case-control study
(PCCS); Prospective Cohort Study (PCS); Retrospective Cohort Study (RCS); Case series (CS). *Percentage of cohort considered for endo-
vascular repair deemed anatomically suitable after contrast-enhanced CT scan. yControl group historical.considering 103 patients with suspected ruptured
AAA, and randomised 32 patients (15 to EVRAR
and 17 to OR). This low rate of patient randomisation
(31%) may be in part explained by the broad exclusion
criteria applied, including: patient unfit for open re-
pair; death before randomisation; inability to give
consent; age; refusal of operation; no team available;
surgeon preference. This trial highlights the signifi-
cant logistical problems related in having a fully
trained, equipped, and committed endovascular team
available at all times.On an intention to treat basis there
was no significant difference in mortality for the EV-
RAR group, 8 of 15 (53%) compared to OR group, 9 of
17 (53%). If we exclude those patients who died after
randomisation but before intervention, mortality for
the EVRAR group, 7 of 13 (54%) including 2 EVRAR
failures requiring open conversions (1 survivor; 1
non-survivor), compared to OR group, 6 of 14 (43%),
non-significant.Of patientswho survived intervention,
there was no significant difference in postoperativecomplications (moderate and severe) for the EVRAR
group, 77%, compared to OR group, 80%. Severe renal
complications were significantly more common in the
EVRAR group, 6 of 11 (55%), compared to OR group,
1 of 14 (7%), p< 0.02. A significant difference in
recorded blood loss and blood transfusion require-
ments is recorded but difficult to interpret when com-
paring minimally invasive, in which intra-abdominal
blood loss cannot be counted, and open surgical proce-
dures. Whilst the authors should be complemented on
their enthusiasm to answer this question, their results
must be considered with caution due to logistical defi-
ciencies in the availability of a 24-hour endovascular
service at their unit, subjective entry criteria, and fail-
ure to recruit sufficient numbers.
The results of non-randomised case series compar-
ing EVRAR, to contemporary or historical series of
open repair (OR) for the treatment of RAAA,13,15,17e
19,22,24,27,30,31,35,38,41,44e46 are compared to the 1 avail-
able RCT16 and presented in Tables 1e4.Eur J Vasc Endovasc Surg Vol 34, December 2007
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Abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA), affects between
1.2% and 7.6% of the population over 50 years of
age in the United Kingdom. The prevalence of AAA
in men is approximately three times greater than in
women, and the incidence increases with advancing
age.1,2 The risk of aneurysm rupture has been shown
to be proportional to aneurysm size, with aneurysms
measuring less than 5.0 cm having an annual rupture
rate of approximately 1% whereas those greater than
7.0 cm in diameter have an annual rupture rate of
over 30%.5,47 The UK Small Aneurysm Trial has
shown that in general, patients benefit from aneurysm
repair when maximum aneurysm diameter exceeds
5.5 cm, at which stage the risk of spontaneous rupture
exceeds the risks of conventional open surgical re-
pair.5 Excellent results can now be achieved with con-
ventional open repair, with some specialist centres
reporting mortality rates of less than 2% and surgeons
in non-specialist units achieving mortality rates of 5%
to 8%.5,7,48 Furthermore, a newer minimally-invasive
technique called endovascular aneurysm repair
Table 2. Length of ICU stay
Study eEVAR
group
OPEN
group
p value
(if quoted)
Franks 2006 1.3 6.1 0.01
Alsac 2005 3 13 0.01
Brandt 2005 4.8 8.5 NS
Kapma 2005 0*y 48*y 0.001
Vaddenini 2005 5* 20* e
Peppelenbosch 2003 46*y 154*y e
Reichart 2003 2.25 13 days e
Resch 2003 1* 3* 0.02
van Sambeek 2002 8*y 62*y 0.004
Yilmaz 2002 2.2 5.2 0.05
Data represents mean unless indicated *median. Values in days
except were indicated yhours.
Table 3. Length of procedure
Study EVRAR
group
OPEN
group
p value
(if quoted)
Hinchcliffe 2006 160 150 0.34
Franks 2006 156 186 0.04
Alsac 2005 156 222 0.1
Brandt 2005 178 207 NS
Kapma 2005 110* 180* 0.001
Vaddenini 2005 143 181 e
Peppelenbosch 2003 154 155 e
Verhoeven 2002 110 122.5 e
van Sambeek 2002 193 203 NS
Yilmaz 2002 173 273 0.05
Ohki 2000 336* 492* e
Data represents mean unless indicated *median. Values in minutes.Eur J Vasc Endovasc Surg Vol 34, December 2007(EVAR), first reported by Parodi in 1991,49 now offers
an alternative treatment in certain patients. Two re-
cent large prospective randomised controlled trials
have compared elective EVAR with conventional
open repair for the treatment of large AAA, and
have shown significant reductions in early complica-
tions and mortality.11,50 However, these trials have
also reinforced the knowledge that open repair is
a successful technique and will remain a common
form of treatment for over half of those patients pre-
senting for whom EVAR is unsuitable on anatomical
grounds or due to other factors.11,50 It is also clear
from these studies that EVAR is associated with
a higher re-intervention rate than open repair,11,50
and registry data would suggest that these re-
intervention rates can remain constant and may
even increase with time.51 As such long-term surveil-
lance is essential after EVAR to monitor for endoleaks
and stent integrity in order to reduce the small but sig-
nificant incidence of late aneurysm rupture (Fig. 1).52
Ruptured abdominal aortic aneurysm
Currently, rupture leads to death in over 80% of those
affected, including 30% to 65% of those who receive
conventional open surgical repair, and is responsible
for over 6800 deaths per annum in the United King-
dom and 2.1% of all deaths in men over 65 years.2,4,9
The haemorrhagic shock and lower torso ischaemia-
reperfusion injury which accompanies RAAA activate
Table 4. Blood loss and transfusion requirement
Study EVRAR
group
OPEN
group
p value
(if quoted)
A: Blood loss
Hinchcliffe 2006 200 2100 0.004
Kapma 2005 200* 3500 0.001
Vaddenini 2005 475 2880 0.0001
Peppelenbosch 2003 1100 2600 e
Reichart 2003 300 4500 e
Resch 2003 800 4000 0.0001
van Sambeek 2002 125* 3400 0.01
Yilmaz 2002 660 3550 0.05
Ohki 2000 400* 2000 e
B: Transfusion requirements
Hinchcliffe 2006 3 6 0.02
Franks 2006 0.86y 10.7y 0.01
Alsac 2005 1520 3075 0.1
Brandt 2005 964 1986 0.02
Kapma 2005 0*y 6y 0.001
Vaddenini 2005 3.78y 6.93y 0.014
Reichart 2003 0 1600 e
Resch 2003 2y 9y 0.02
Ohki 2000 3*y 6y e
A: Data represents mean unless indicated *median. Values in milli-
litres. B: Data represents mean except were indicated *median.
Values in millilitres except were indicated yunits.
677Endovascular RAAA Repairmultiple inflammatory pathways in the body induc-
ing a harmful proliferative systemic inflammatory
response syndrome characterized by immune cells
activation, pro-inflammatory mediator production
and widespread vital organ injury (heart, lungs, liver,
kidney, gut, etc.). The sequential failure of these
organs despite intensive care support, once estab-
lished leads to death in over 70% of cases.53e55 De-
tailed risk analysis and scoring systems have been
shown to predict non-survivors in certain groups
but individual patient outcomes cannot be accurately
predicted.9,56 Clinicians have been reticent to apply
these scoring systems rigidly as to do so would serve
to preclude most patients with RAAA from surgical
repair, condemning them to certain death.9 It is also
now clear that those patients who undergo successful
open repair of RAAA enjoy a post-operative quality of
life similar to the ‘‘normal population’’.57
Endovascular ruptured aneurysm repair (EVRAR)
Since the first description of the EVAR technique,49
many specialised vascular surgery centres have adop-
ted its use in the elective treatment of abdominal
aortic aneurysm, where its use has contributed to a
reduction in early postoperative morbidity and
mortality.11 Furthermore, several studies have con-
firmed that the use of EVAR, especially under local
anaesthesia, reduces the physiological insult to the
body as compared to conventional open surgical
repair.12,58 These potential benefits have led several
experienced units to offer endovascular ruptured
aneurysm repair (EVRAR), as an alternative to con-
ventional open surgery, in selected patients.59,60 These
early reports have suggested EVRAR is feasible and
may be achieved with a morbidity and mortality in
RAAA
(Clinical suspicion)
Stable
(GCS 15/BP >70)
CT-scan
(EVAR suitable)*
Survivor
(Hardman <3)†
NO
YES
Surgery
Open AAA repair
 
YES 
No-surgery
Pathway for dying
NO
EVAR
NO
YES
Fig. 1. Algorithm for the treatment of patients presenting
with ruptured abdominal aortic aneurysm. *EVAR suitable
(see Table 5), yHardman criteria.9selected patients which is at least equivalent to best
conventional surgical practise.14,25,35
Selection of cases on the basis of precise anatomical
suitability for elective EVAR has been shown to be as-
sociated with a much lower rate of re-intervention,
morbidity, and procedure-related cost.12,51,61 Evidence
from several studies has shown that the aneurysm
morphology is significantly more challenging for
endovascular techniques in those assessed for
RAAA compared with those undergoing elective
EVAR.38,62,63 Most authors have used established cri-
teria derived from elective EVAR to determine ana-
tomical suitability for EVRAR. However, reported
studies reveal substantial variation in the anatomical
inclusion and exclusion criteria employed, with ana-
tomical suitability rates ranging from 34% to
100%.15,16,22,31,38,44 In particular many groups accept
inferior proximal neck anatomy which would pre-
clude patients from elective EVAR, suggesting a trend
to be more inclusive in these high risk patients.64
Whilst there is no long term follow-up data available
for patients undergoing EVRAR, evidence from elec-
tive EVAR would suggest that relaxation of the crite-
ria for anatomical suitability may lead to future
problems, such as increased rates of endoleak, graft
displacement, complications, re-interventions or the
need for open conversion.51,65
The majority of centres use contrast-enhanced
computed tomographic angiography (CTA) to assess
the anatomical suitability of aneurysms for
EVRAR.15,16,22,31,38,44,66e68 Some centres advocate in-
tra-operative calibrated angiography as an effective al-
ternative in order to reduce pre-operative delays.35,69
However, angiography does not clearly show lumi-
nal thrombus, which could adversely affect the abil-
ity to obtain a secure seal at the proximal fixation site
risking endoleak or late device migration. Generous
device oversizing is advocated and can improve
the chances of a primary seal.64,65 However, concerns
have been raised in relation to the effect of oversiz-
ing on aneurysm neck dilation and late failure.70 Re-
cent studies suggest CTA assessment can be safely
carried out in rupture patients, suggesting any diag-
nostic delays may not be clinically important.66,71 In-
deed the majority of patients with RAAA who are
not operated upon survive for more than two hours
after hospital admission and maintain a satisfactory
systolic blood pressure greater than 80 mmHg with
minimal fluid resuscitation, which would allow suf-
ficient time for radiological assessment in most spe-
cialist centres.66,71 In Table 5, we summarize current
anatomical suitability criteria applied for emergency
EVRAR in comparison to established criteria for elec-
tive EVAR.15,16,22,31,38,44,66e68Eur J Vasc Endovasc Surg Vol 34, December 2007
678 D. W. Harkin et al.In the haemodynamically unstable patient with
RAAA, rapid control of progressive haemorrhage at
the aortic rupture site during open surgery is often
considered paramount. In the setting of endovascular
repair, this control may be achieved by swift endog-
raft placement and deployment, or by placement and
inflation of a balloon occlusion device in the aorta
proximal to the rupture site.35,44,72 The reported
studies describe the use of both, aorto-uni-iliac (AUI)
or aorto-bi-iliac (ABI) devices for EVRAR. Aorto-uni-
iliac devicesmay have the advantage of ease in deploy-
ment, and therefore rapid control of haemorrhage, but
this approach must be accompanied by a surgical fem-
fem crossover bypass graft to provide blood flow to the
contralateral lower limb. Aorto-bi-iliac devices, or
modular bifurcated grafts, give a better anatomical
result but often require more deployment time for
cannulation of the contralateral graft limb. However,
these are the device of choice for elective EVAR, such
that many endovascular specialists are familiar with
their capabilities can obtain temporary control by
initial proximal deployment of the graft body, delaying
release of the contralateral limb until cannulation is
imminent or the patient has been stablized.72 Exposure
of the femoral arteries for endograft placement under
local anaesthetic is advocated by many and can reduce
the haemodynamic instability.73 Furthermore, a policy
of permissive hypotension to reduce bleeding and
prevent re-bleeding from the contained aortic
rupture site,13,16 is applied in all studies but with
wide variation in the lowest tolerated systolic blood
pressures (SBP), with most authors considering an
un-assisted SBP greater than 70 mmHg as indicative
of stability).13,16,40 However, it is notable that even
when SBP as low as 50 mmHg were permitted by
Table 5. The Anatomical criteria used for consideration of EVRAR
Criteria Elective
EVAR
Emergency
EVRAR
Comment
Neck diameter (max) 28 mm 32 mm Allow for >10%
oversize
Neck length (min) 15 mm 8 mm Consider proximal
fixation
Neck angulation (max) 60 90 Consider flexible
device
Neck conicity (max) 4 mm/cm 8 mm/cm Consider oversize
Neck quality Moderate Poor Consider oversize
CIA/EIA diameter
(min)
9 mm 6 mm Consider uni-iliac
device or conduit
CIA/EIA diameter
(max)
16 mm 22 mm Consider uni-iliac
device
Iliac tortuosity Moderate Severe Consider uni-iliac
device or conduit
Data represents for elective EVAR average inclusion criteria for
EVAR Trials, and for emergency EVRAR a summary of published
contemporary practise. Abbreviations: common iliac artery (CIA);
external iliac artery (EIA).Eur J Vasc Endovasc Surg Vol 34, December 2007some,without increase in end-organ injury, such as vis-
ceral ischaemia.40
Patient outcomes after EVRAR
For elective aneurysm repair, EVAR is associated with
significant reductions in early complications and mor-
tality.11,50 Paradoxically, this early mortality benefit is
not sustained at one-year, were the mortality from
EVAR is comparible to open repair but at an increased
cost.11 Furthermore, high-risk patients deemed unfit
for elective open surgical repair, faired no better
with EVAR than with best medical management in
terms of aneurysm-related or all-cause mortality, sug-
gesting that unfitness for open surgery as judged in
these studies may be an indicator for reduced life-
expectancy.10 Notable also from the EVAR 2 Trial is
that the peri-procedural morality rate of 9% in these
high-risk patients was significantly greater than their
lower risk counterparts in EVAR 1 Trial.10,11 However,
the risk/benefit analysis is different in patients with
RAAA as failure to treat means inevitable death and
conventional open surgery continues to carry a very
significant risk of mortality, 35% to 70%. Endovascular
ruptured aneurysm repair (EVRAR) is less invasive,
reduces surgical stress, reduces haemodynamic insta-
bility, and can be achieved with a local or loco-
regional anaesthesia. The only published RCT showed
no benefit for EVRAR in terms of mortality or compli-
cations.16 Indeed mortality in both EVRAR and
conventional open groups, in a heavily selected pop-
ulation were unstable patients were excluded, was
high at 53% compared to many contemporary re-
ports.16 In the non-randomised studies EVRAR was
associated with a low mortality rate, average 17%
(range 0e45), compared in some studies to contempo-
rary or historical control groups undergoing open
repair, average 34% (range 0e70), for patients with
ruptured abdominal aortic aneurysm. Furthermore,
this mortality benefit mirrors a procedural-related
reduction in blood loss, transfusion requirements,
and length of ICU stay (Tables 2e4). These perceived
benefits are generally attributed to a reduction in the
physiological insult to the patients, as EVRAR obvi-
ates the need for laparotomy, exposure and handling
of abdominal contents, and aorto-iliac dissection and
clamping. In the majority of the studies EVRAR was
conducted under general anaesthetic, although it is
clear that even AUI device placement with surgical
femoro-femoral bypass graft can be achieved under
local anaesthetic regimes.73 However, results from
selected populations in these non-randomised studies
must be interpreted with caution.
679Endovascular RAAA RepairImplications for vascular services
A distinct learning curve effect is noted in the studies
involving EVRAR, which especially is important as all
of these arise from centres with already considerable
experience with elective endovascular aneurysm pro-
cedures.14,25,35,44 The more recent studies show
a greater reduction in procedure times, mortality
and complication rates.18,22,45 As has been seen with
elective EVAR practice, advancements in stent-graft
design and endovascular techniques have lead to im-
proved outcomes.51 Re-intervention rates also appear
comparable with those seen with elective endovascu-
lar repair.51,74 However, long-term data are needed in
order to truly assess if EVRAR is a durable treatment
in relation to endoleak, stent-graft integrity, and late
rupture risk. It is clear that the introduction of an
EVRAR service has substantial cost implications, in
terms of staff, fixed resources and procedure-associ-
ated equipment. In order to provide a comprehensive
24-hour service the necessary team of surgeons, radi-
ologists, anaesthetists, radiographers, nurses and
technicians need to be available at all times.15 This
may impact on the transferability of this technique be-
yond specialist centres. These logistical deficiencies
were highlighted by the low recruitment rate to the
RCT even from a very experienced endovascular
centre.16 Whilst, most units had a wide range of
stent-graft stock available to cope with the variable
anatomy encountered, the majority of patient can be
treated with a small range of devices made available
by satisfactory arrangement with a commercial part-
ner. Surveillance protocols in respect to imaging after
EVRAR may be similar to elective practice, although
the frequency of medium and late complications is
as yet unknown and may require a high rate of re-
intervention by endovascular or open means, in rela-
tion to endoleak, device migration, strut fracture,
limb occlusion or late rupture.15,70,75
Study limitations
In the absence of high-quality randomised controlled
trials, we are unable to fully evaluate the role of emer-
gency endovascular ruptured abdominal aortic aneu-
rysm repair (EVRAR). Early results from specialist
centres show this technique is feasible. Data suggest-
ing reduced morbidity and mortality in selected pa-
tients must be interpreted with caution due to the
lack of randomisation in these studies. Further trials
to evaluate the role of EVRAR in the treatment of
RAAA are required. These trials should be methodo-
logically adequate in terms of sample sizes, treatmentstandardization and duration of follow up. Clinically-
relevant outcomes such as rate of major complications,
open-conversion, aneurysm exclusion, endoleak, rup-
ture, and mortality should be assessed. However,
accumulating evidence from non-randomised studies,
which show significant reductions in mortality in
selected patients deemed suitable for endovascular
repair, may raise ethical concerns in relation to in-
formed consent and randomisation of these patients
to open repair. Large prospective studies are required
to validate the acceptable anatomical criteria for
EVRAR in RAAA. Furthermore, longitudinal studies
are required to assess the long-term durability of
this form of treatment in terms of re-intervention
rate, open-conversion rate, and rupture-free survival.
Conclusions
Accumulating published data suggests that endovas-
cular ruptured abdominal aortic aneurysm repair
(EVRAR) is feasible in selected patients in institutions
with experience of endovascular techniques for the
treatment of ruptured abdominal aortic aneurysm.
Furthermore, in those selected patients EVRAR may
also be accompanied by reductions in blood loss, In-
tensive Care Unit (ICU) stay, and mortality. However,
a significant proportion of patients with ruptured
abdominal aortic aneurysm remain anatomically
unsuitable for contemporary endovascular repair,
and whilst relaxation of exclusion criteria may make
EVRAR feasible, this is likely to increase device and
aneurysm related complications.
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